UK-approved Mounjaro weight loss injection
In the UK, a diabetes medication known as the “King Kong” of weight-loss shots has been approved to treat obesity.
You feel fuller and eat less when you take tirzepatide, also known as montjaro.
Its users have lost five percent of their body weight in trials, and UK regulators have now declared it safe and effective enough for sale and prescription in the country.
In contrast to Wegovy, a similar injection, it is not yet advised by the NHS.
However, it can be used by the NHS for diabetes.
watchdog on healthcare spending Its application to obesity is being reviewed by the National Institute for Health and Care Excellence (NICE), which is expected to submit a report in March 2024.
Similar in how they function, Wegovy and Mounjaro are pre-filled injection pens that patients self-administer by putting a dose under their skin on their thigh or stomach.
They have the potential to significantly reduce weight.
However, studies show that after stopping treatment, users frequently gain weight again.
How dangerous are drugs used to lose weight?
Suicide risk assessment conducted on weight loss jabs
However, these medications can have adverse effects; the most frequent ones are vomiting, diarrhea, nausea, and constipation.
Furthermore, although popular in the US and supported by numerous celebrities, the jabs are neither a magic bullet nor a replacement for a balanced diet and regular exercise.
Experts warn that Mounjaro could have an impact on the effectiveness of the birth control pill. When starting Mounjaro and after each dose increase, women who are taking it should think about using additional contraception, like condoms, or switching to a non-oral method.
Certain private clinics and specialized NHS weight-loss management services are offering Wegovy shots, which contain the medication semaglutide. GPs are also going to be able to offer it.
Although there aren’t many in stock, some High Street chains are prescribing and selling it as well.
Tens of thousands of patients in England could benefit as more doses become available, according to the NHS.
Mounjaro may also be added to the list of potential NHS treatments in the future.
It can be used by adults who are obese or overweight and have weight-related health issues, such as high blood pressure, according to the UK’s drug regulator, the MHRA.
It can be used by adults who are obese or overweight and have weight-related health issues, such as high blood pressure, according to the UK’s drug regulator, the MHRA.
“Although further approvals are needed to use this in the NHS, Mounjaro has the potential to help thousands of people living with obesity and support those suffering from weight-related illnesses – if used alongside diet and physical activity,” stated Health and Social Care Secretary Steve Barclay. Combating obesity could shorten wait times and save the National Health Service billions of pounds.”